Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, December 22, 2021
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
Tue, December 21, 2021
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
Jason Butler Maintained (ACAD) at Buy with Increased Target to $42 on, Dec 21st, 2021
Jason Butler of JMP Securities, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Buy with Increased Target from $39 to $42 on, Dec 21st, 2021.
Jason has made no other calls on ACAD in the last 4 months.
There are 4 other peers that have a rating on ACAD. Out of the 4 peers that are also analyzing ACAD, all agree with Jason's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jay Olson of "Oppenheimer" Maintained at Hold with Increased Target to $23 on, Thursday, December 9th, 2021
- Salveen Richter of "Goldman Sachs" Maintained at Hold with Increased Target to $28 on, Wednesday, December 8th, 2021
- Vamil Divan of "Mizuho" Maintained at Hold with Increased Target to $26 on, Tuesday, December 7th, 2021
- Jeffrey Hung of "Morgan Stanley" Maintained at Hold with Increased Target to $24 on, Tuesday, December 7th, 2021
